The Dangers of Vaping on Lung Health

Dec.26.2022
The Dangers of Vaping on Lung Health
E-cigarettes are not a safer alternative to smoking and can cause lung damage and cancer due to harmful chemicals.

Electronic cigarettes or e-cigarettes have become a popular alternative for those who want to quit smoking. However, the truth is that both e-cigarettes and traditional cigarettes are harmful and can have an impact on various organs in the body, including the lungs. Unfortunately, many individuals misunderstand the risks associated with e-cigarettes and tend to ignore their potential impact on lung health.


E-cigarettes are devices that heat liquid into an aerosol for inhalation into the lungs. Unlike traditional cigarettes which produce smoke by burning tobacco, e-cigarette liquids contain various combinations of ingredients, including nicotine, other chemicals, flavorings, and toxins.


In the past 24 to 36 months, I have seen a significant increase in the number of patients using electronic cigarettes," reported Stephen Broderick, a lung cancer surgeon at Johns Hopkins.


The following are a series of effects of e-cigarettes on the lungs that one needs to be aware of.


Popped popcorn lung


Popcorn lung, also known as bronchiolitis obliterans (BO), is a rare respiratory disease caused by damage to the small airways in the lungs. The disease was first discovered in popcorn factory workers. The culprit was identified as diacetyl, a food additive used to simulate the flavor of butter in microwave popcorn.


Acetoin is commonly added to e-cigarette liquids to improve their flavor. Inhaling this substance can cause inflammation of the smallest airways in the lungs and lead to permanent scarring, thereby causing difficulty in breathing. There is currently no permanent treatment for Popcorn Lung, which presents with symptoms such as coughing, wheezing, chest pain, and breathing difficulties.


2. Lipoid Pneumonia.


Unlike typical pneumonia caused by infection, lipoid pneumonia occurs when fatty acids (components of fat) enter the lungs. Lipoid pneumonia related to vaping occurs when oily substances in e-cigarettes are inhaled, triggering inflammation in the lungs. Symptoms of lipoid pneumonia include chronic cough, difficulty breathing, and coughing up mucus mixed with blood or containing blood.


According to Broderick, "There is no effective treatment for lipoid pneumonia other than supportive care, as the lungs will heal on their own. The most important thing you can do is determine the cause." He furthered his statement.


3. Primary spontaneous pneumothorax


Primary spontaneous pneumothorax or lung collapse occurs when there is a hole in the lung through which oxygen escapes. This may be a result of injury, such as gunshot or stabbing, or the rupture of a small tear in a bubble at the top of the lung.


Smoking and vaping e-cigarettes often increase the risk of these fluid-filled sacs or bubbles bursting, ultimately leading to collapsed lungs.


We always ask them if they smoke, and they often say, 'No, I don't smoke. But I use e-cigarettes.' We now advise patients that if they want to avoid future lung collapse and surgery, they should avoid smoking or using e-cigarettes.


Signs of pulmonary collapse include severe pain in the chest or shoulder and difficulty breathing. Oxygen therapy and rest may be necessary preparations to cure collapsed lungs. However, more serious cases may require a chest tube to drain the leaked oxygen from the body cavity or surgery to repair a hole in the lungs.


Lung Cancer


Electronic cigarettes may increase the risk of cancer due to the many chemicals they contain that can enter the lungs.


We know that smoking tobacco causes tiny particles to deposit deep in the bronchial tree and can lead to the development of cancer. Vaping may have a similar effect," said Broderick.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

EU Tobacco Rules Face Pushback as Analysis Says 90% of Consultation Responses Raised Objections
EU Tobacco Rules Face Pushback as Analysis Says 90% of Consultation Responses Raised Objections
An analysis by We Are Innovation says more than 90% of over 82,000 responses to the European Commission’s public consultation on the Tobacco Products Directive revision raised at least one substantial objection to the proposed regulatory direction.
Jul.13
Argentina Updates Health Warning Rules to Include Vapes and Nicotine Pouches
Argentina Updates Health Warning Rules to Include Vapes and Nicotine Pouches
Argentina’s Ministry of Health has updated its health warning rules for tobacco and nicotine products, adding e-cigarettes, vapes, heated tobacco products, sticks and nicotine pouches to mandatory warning requirements.
Jul.08
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
A report by KFF Health News says that as the Trump administration pursued a series of policies favorable to the nicotine and tobacco industry, President Donald Trump increased his holdings in tobacco companies while benefiting from substantial industry-linked political donations, prompting questions from public health advocates about potential conflicts of interest and regulatory direction.
Jun.12
Innovation, Insights and Networking: NUBIZ Brings the Global NGP Industry Together in Dortmund
Innovation, Insights and Networking: NUBIZ Brings the Global NGP Industry Together in Dortmund
The market for next-generation products is expanding rapidly, with vapes, e-cigarettes, pouches, snus and heat-not-burn products among the industry’s most innovative segments. As part of InterTabac, NUBIZ provides a central platform for reduced-risk tobacco and nicotine products, bringing together global leaders and newcomers from 15 to 17 September. The show combines market insights, product comparisons, networking, a high-level conference programme and exclusive side events.
Jun.03
2Firsts Interview | InterTabac 2026 Adapts to a More Complex Tobacco and Nicotine Market
2Firsts Interview | InterTabac 2026 Adapts to a More Complex Tobacco and Nicotine Market
As InterTabac 2026 approaches, Sabine Loos, Managing Director of Westfalenhallen Unternehmensgruppe, tells 2Firsts that global tobacco trade fairs are evolving beyond product display. With new nicotine categories, shifting regulation and more complex supply chains reshaping the industry, InterTabac is positioning itself as a platform for market insight, regulatory discussion and global business connection.
Special Report
Jul.02
Sesh touts independence, 8VC backing and retail reach as it challenges tobacco-owned pouch brands
Sesh touts independence, 8VC backing and retail reach as it challenges tobacco-owned pouch brands
U.S. nicotine pouch brand Sesh has emphasized its independence from Altria, Philip Morris International and British American Tobacco, along with backing from investors including 8VC, celebrity supporters and a retail footprint of more than 7,500 stores, as it seeks to differentiate itself in a market where major pouch brands are owned by large tobacco companies.
Regulations
Jul.07 by 2Firsts Perspectives